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Using a Solid-Phase Ribozyme Aminoacylation
System to Reprogram the Genetic Code
tRNA synthetases (E. coli ARSs), and thus called ortho-
gonal tRNA (otRNA). They have so far succeeded in evolv-
ing several sets of TyrRS mutants capable of charging
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University at Buffalo Phe analogs onto this particular otRNA (generally each
TyrRS mutant is designated to one Phe analog) andThe State University of New York
Buffalo, New York 14260 expressing proteins containing Phe analogs in E. coli
under the conditions where natural amino acid concen-
trations were controlled [7, 9–12].
The above demonstration represents a powerful strat-Summary
egy to evolve a naturally occurring ARS. However, a
drawback of this method is that since the individualHere, we report a simple and economical tRNA amino-
acylation system based upon a resin-immobilized ri- mutant is generally specific to its Phe analog, additional
evolution is required to alter the ARS specificity whenbozyme, referred to as Flexiresin. This catalytic system
features a broad spectrum of activities toward various a new kind of analog is used. This would not be a routine
process for many investigators because it requiresphenylalanine (Phe) analogs and suppressor tRNAs.
Most importantly, it allows users to perform the tRNA multistep experiments, such as preparation of the initial
libraries, optimization of the selection conditions, andaminoacylation reaction and isolate the aminoac-
ylated tRNAs in a few hours. We coupled the Flexiresin characterization of the mutants. Moreover, the above
orthogonal ARS/tRNA pair selected in E. coli must besystem with a high-performance cell-free translation
system and demonstrated protein mutagenesis with reevolved in order to be applied to other organisms. This
is in contrast to the aforementioned cell-free syntheticseven different Phe analogs in parallel. Thus, the tech-
nology developed herein provides a new tool that sig- method, which is more flexible toward various nonnatu-
ral amino acids and suppressor tRNAs that are ortho-nificantly simplifies the procedures for the synthesis
of aminoacyl-tRNAs charged with nonnatural amino gonal in prokaryotic [3] and eukaryotic translation sys-
tems [13].acids, which makes the nonnatural amino acid muta-
genesis of proteins more user accessible. Here, we report a novel and highly practical tRNA
aminoacylation system based upon a resin-immobilized
ribozyme, facilitating the step for the synthesis of non-Introduction
natural aminoacyl-tRNAs (Figures1A and 1B). The method
is simple; a user-specified tRNA and a Phe analog areSite-specific mutagenesis of proteins with nonnatural
amino acids allows us to utilize unique functional groups reacted on this reusable ribozyme resin, and the eluent
containing the desired aminoacyl-tRNA can be used inthat are unavailable from the repertoire of natural amino
acids, thereby adding a new dimension to protein re- a cell-free transcription-translation coupling system
(Figure 1C). In support of this claim, we have demon-search [1, 2]. In the last two decades, this technique
has been used for the isolation of various proteins car- strated the incorporation of seven Phe analogs with a
variety of p-substitutions into green fluorescent proteinrying the desired nonnatural amino acids [3]. However, in
spite of its tremendous potential toward the engineering (GFP) at one or two sites specifically. It should be noted
that the entire process, including tRNA charging, in vitroand studying of proteins, this technique has not been
widely used. This is simply because the method is tech- translation, and purification of protein, can be done in
one day. Thus, the ribozyme aminoacylation system innically difficult and laborious. Particularly, the synthesis
of a suppressor tRNA charged with nonnatural amino combination with a highly efficient cell-free translation
system advances the method of the protein nonnaturalacids requires multiple steps, which involve chemical
aminoacylation of a dinucleotide (pdCpA), HPLC purifi- amino acid mutagenesis to a more user-accessible tech-
nology.cation, enzymatic ligation with the tRNA fragment that
lacks the 3-CA, and removal of the N-protecting group
[4–6].
Results and DiscussionSchultz and colleagues have recently made remark-
able progress in evolving tyrosyl-tRNA synthetase (TyrRS)
Resin-Immobilized Ribozymemutants derived from Methanococcus jannaschii (M.
The ARS ribozyme used for the development of thejannaschii) [7, 8]. They have developed a genetic selec-
resin-immobilized form is a de novo catalyst that wastion method where active TyrRS mutants can be se-
originally selected from a pool of random RNA se-lected based on the charging activity of phenylalanine
quences [14]. The first generation ribozyme was further(Phe) analogs onto a M. jannaschii tRNATyrCUA. This tRNA
optimized by a combination of in vitro evolution andis inert against endogenous Escherichia coli aminoacyl-
systematic engineering, affording a 45 nucleotide (nt)
ribozyme [15]. This ribozyme, called Flexizyme, displays
*Correspondence: hsuga@buffalo.edu
a broad spectrum of activity toward various tRNAs and2 Present address: Research Center for Advanced Science and Tech-
Phe analogs, the properties of which would be suitablenology, University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo, 153-
8904, Japan. for nonnatural amino acid mutagenesis.
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Figure 1. Overview of Flexiresin-Facilitating Nonnatural Amino Acid Figure 2. Aminoacylation of Engineered Suppressor tRNAs with
Mutagenesis Phe and Phe Analogs by Flexiresin
(A) The process of nonnatural amino acid mutagenesis of protein (A) Cyanomethyl ester-activated Phe analogs used in this study.
using Flexiresin. Flexiresin is capable of charging various Phe ana- These amino acids have various groups at the p-position of phenyl
logs onto various tRNAs, and therefore, this method allows users ring.
to utilize desired pairs of Phe analog and tRNA. (B) Aminoacylation analysis by streptavidin-dependent gel-shift
(B) By simply mixing a Phe analog and a tRNA that are chosen by assay. Amino acid-specific biotinylation was done after an amino-
users, the tRNA is charged with the nonnatural amino acid on the acylation reaction to detect aminoacyl-tRNA.
solid phase of Flexiresin in 2 hr. (C) Aminoacylation efficiency. The middle of the error bar represents
(C) The aminoacyl-tRNA product is added to a high-performance the mean score from three different trials. The error bar represents
cell-free translation system coupled with transcription in the pres- a standard deviation of all trials. Abbreviations: a, Aminoacyl-tRNA-
ence of a mutant protein DNA template. The mutant gene contains streptavidin complex; b, unaminoacylated tRNA; *, aminoacyl-tRNA
an amber codon at a specific position. An amber suppressor tRNA containing dC75, which was prepared by the chemical aminoacyla-
suppresses the amber codon and incorporates a Phe analog. Alter- tion method; **, tRNA that has a ACCC 4-base anticodon instead
natively, a 4-base codon and frame-shift suppressor tRNA pair can of CUA anticodon; Phe, phenylalanine; Iod, p-iodophenylalanine;
be used, and a Phe analog is incorporated by the “programmed Bzo, p-benzoylphenylalanine; Bip, p-biphenylalanine; Bio, p-bio-
frame-shift” suppression. tinyl-aminophenylalanine; Azi, p-azidophenylalanine; Azo, p-phe-
nylazophenylalanine; SAv, streptavidin.
In order to make the Flexizyme aminoacylation system
more practical, we have carried out 3-end specific im- was incubated with tRNAAsnCUA and Phe cyanomethyl
ester (Phe-CME) in the presence of Mg2 for 2 hours.mobilization of the ribozyme onto a resin [16]. Flexizyme
was engineered to bear an additional 20 adenosines at Following removal of the supernatant, the resin was
washed with buffer containing no Mg2 to elute the de-the 3-end, and the cis-diol of this terminal adenosine
was converted to the 3-dialdehyde by periodate oxi- sired Phe-tRNAAsnCUA. After biotinylation of the -amino
group of Phe, the product was analyzed using a strep-dation. This construct was then coupled to a hydrazine
resin, followed by mild reduction of the hydrazide bond, tavidin-dependent gel-shift assay, revealing a yield of
approximately 50% of Phe-tRNAAsnCUA (Figures 2B andyielding an irreversible covalent bond. The preparation
process generally takes a few hours, giving 80%–90% 2C, lane 2). In comparison, the chemoenzymatic synthe-
sis of Phe-tRNAAsnCUA containing dC75 gave approxi-immobilization efficiency. The resin-immobilized Flexi-
zyme, referred to as Flexiresin, is stable and can be mately a 30% yield in our laboratory (Figures 2B and
2C, lane 1; although this value could vary from 30%stored for months without any loss of activity.
to 60% depending on the purity of pdCpA-Phe). Most
significantly, neither HPLC purification nor multistepAminoacylation of Suppressor tRNAAsnCUA
Flexiresin was tested for aminoacylation activity onto procedures are involved in the aminoacylation of tRNA
when using Flexiresin, and hence, the time required foran engineered suppressor tRNA, derived from E. coli
tRNAAsnCUA [17]. This suppressor tRNA was engineered the synthesis of Phe-tRNAAsnCUA is significantly shortened
from days to a few hours.to have a G73A mutation, which was found effective for
enhancing its inertness against endogenous ARSs in an We extended the aminoacylation testing further with
six different Phe analogs that have a variety of p-substi-E. coli cell-free translation system (vide infra). Flexiresin
A Ribozyme Aminoacylation System for Translation
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tutions ranging from small to large groups (Figure 2A).
Remarkably, Flexiresin is able to charge all these Phe
analogs with yields ranging from 20% to 50% (Figures
2B and 2C, lanes 2–8). This result clearly indicates that
the flexible nature of Flexizyme is maintained in Flexire-
sin, but there are two technical advantages of using
Flexiresin over Flexizyme. First, Flexiresin is reusable.
A simple wash with water regenerates Flexiresin for the
next use in minutes. Indeed, we have used it at least
ten times and have no reason to believe that it could
not be used more times. Second, the desired aminoacyl-
tRNA is readily isolated. Upon the addition of tRNA to
Flexiresin, tRNA is immobilized over 90%. Thus, the un-
reacted amino acid substrate and undesired side prod-
ucts can be readily removed by simply taking the super-
natant after reaction. Moreover, the aminoacyl-tRNA is
separated from the catalyst by the simple elution proce-
dure. This convenient purification procedure of amino-
acyl-tRNA is advantageous when the application to cell-
free translation or other applications were considered,
because any unnecessary contaminants in the reaction
may reduce the efficiency of the translation. These two
features unequivocally make this technology simple,
practical, and economical, particularly when scale up is Figure 3. Mutant Genes Used in This Study
required. (A) Amber (TAG) codon was introduced at position 151 (#1) for incor-
poration of Phe analogs. Asterisks indicate the residues that are
not incorporated into protein.
(B) Amber and a 4-base (GGGT) codon were introduced at 151 (#1)Nonnatural Amino Acid Mutagenesis
and 178 (#2) positions, respectively, for the incorporation of twoTo demonstrate the utility of Flexiresin toward protein
Phe analogs. The amino acids at 151 and 178 are present on themutagenesis, we chose a high performance E. coli in
surface of GFP, which should not perturb the protein folding.vitro transcription-translation coupling system available
from Roche, called rapid translation system (RTS). GFP
was used as a model protein for expression with nonnat- These values translate to an expression efficiency of
177 g/mL and 76 g/mL, respectively. Interestingly,ural amino acids, since formation of the full-length pro-
tein can be readily detected by fluorescence [18]. We the difference in the efficiency between the wild-type
and mutant proteins in the semipreparative scale wasselected the Tyr151 residue for a site-specific mutation,
which is located on the surface of GFP and therefore the greater than that observed in the analytical scale (Figure
4A, the ratio of full-length protein in lane 6 to lane 1 wasmutation should not interfere with fluorescent activity
(Figure 3) [19]. As expected, the 151 amber mutation approximately 9:10). We attributed this to the higher
concentration of Met, which enhanced the expressionon the gfp expression plasmid halts elongation, thus
producing a truncated protein (Figure 4A, lane 2) that level of the wild-type more than that of the mutant. We
speculated that the addition of Met could result in accel-has no fluorescence (Figure 4B, lane 2). The addition of
tRNAAsnCUA alone does not suppress the amber mutation erating the initiation step. Perhaps the expression of
the wild-type protein was effectively enhanced because(Figure 4A, lane 3), confirming the inertness of this tRNA
against endogenous ARSs in RTS. As a positive control, initiation could be the rate-limiting step in this case. On
the other hand, in the case of expression of the mutantwe prepared Phe-tRNAAsnCUA, containing dC at position
75, by means of the traditional chemoenzymatic method, proteins, other steps related to the suppression event,
such as amber suppression or peptidyl-transfer of theand used it to confirm the suppression activity of this
tRNA (Figure 4A, lane 4). We then prepared tRNAAsnCUA nonnatural amino acid, might be the rate-limiting step.
Further investigations are necessary to draw a morecharged with Phe or its analogs by using Flexiresin and
tested the suppression of the amber codon in parallel definitive conclusion regarding this observed difference.
The isolated GFPs were analyzed to confirm the incor-(Figure 4A, lanes 5–11). In all cases, the amber mutation
was effectively suppressed, yielding the full-length pro- poration of Tyr and Ido into position 151. The protein
was digested with trypsin, and the resulting fragmentsteins. The suppression efficiency observed was in most
cases over 30% and as high as 80% (Figure 4C). were analyzed by LC-MS. We detected the expected
peptide fragment containing Tyr (observed mass To assess the expression efficiency, the translation
was scaled up to a semipreparative level where a higher 972.6 m/z, calculated mass  972.5 m/z) for the wild-
type fragment and that containing Ido (observed massconcentration of methionine (Met) was used compared
with the analytical scale (2 mM instead of 0.05 mM, 1027.9 m/z, calculated mass  1027.4 m/z) for the
mutant fragment (see Supplemental Data available on-according to the manufacture’s protocol), and the full-
length protein was purified via histidine tag. In a 110 l line at http://www.chembiol.com/cgi/content/full/10/11/
1077/DC1). This result confirmed the incorporation ofscale translation reaction, 19.5 g of the wild-type GFP
was isolated, while 8.4g of the Tyr151Ido was isolated. the Phe analog at the expected position.
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Figure 4. Nonnatural Amino Acid Mutagene-
sis of GFP at 151
(A) SDS-PAGE analysis of translation reac-
tion. Lane 1, wild-type; lane 2, in the absence
of suppressor tRNAAsnCUA; lane 3, in the pres-
ence of suppressor tRNAAsnCUA; lane 4, in
the presence of chemically synthesized Phe-
tRNAAsnCUA containing dC75; lanes 5–11, in
the presence of aminoacyl-tRNAAsnCUA pre-
pared by the Flexizyme-resin. Abbrevia-
tions: aa-tRNA, aminoacyl-tRNAAsnCUA; x, no
tRNAAsnCUA;, no aa-tRNAAsnCUA; wt, wild-type;
(a), full-length protein; (b), truncated peptide.
The band below (b) is an unknown truncated
peptide.
(B) Fluorescence activity of each sample in
(A), analyzed by Molecular Imager FX.
(C) Suppression efficiency. The middle of the
error bar represents the mean score from
three different experiments. The error bar
represents a standard deviation of all trials.
The suppression efficiency was calculated
based on the radioactivity of bands (a) and
(b), fitted to (a)/[(a)(b)x5/3]. Intensity of (b)
was corrected in order to reflect the number
of Met residues, based on the consideration
that the full-length and truncated proteins
contain 5 and 3 Met, respectively. We ex-
cluded the shortest peptide fragment (the
fastest migrating band) from the calculation
of suppression efficiencies, since this trunca-
tion might occur due to an abnormal termina-
tion, such as a drop-off of peptidyl-tRNAs
from the ribosome [39–41]. It should be noted
that this termination was also observed in the
wild-type expression (Figure 4A, lane 1).
Therefore, in the case of mutant expression,
translation might pause at the amber codon,
resulting in an increase in the chance of a
drop-off event.
Posttranslational Modification Double Site-Specific Mutagenesis with Two
Nonnatural Amino AcidsAlthough we have shown in Figure 4 that most Phe
analogs were incorporated into GFP efficiently, the in- Like Flexizyme, Flexiresin does not recognize the antico-
don sequence of tRNA (Figures 1B and 1C, lane 9). Thiscorporation of Bio (lane 9) was modest compared with
the other Phe analogs. This is most likely an intrinsic feature allows us to create a second set of Phe analogs
and suppressor tRNAs with an anticodon other thanlimitation of the translational machinery against nonnat-
ural amino acids with large side chains. To avoid this amber. Programmed frame shift or the so-called “4-base
codon” is an alternative approach to expand the geneticproblem, a Phe analog bearing an electrophile, such as
a ketone, can be incorporated into proteins and then a code [21]. When the programmed frame-shift mutation
is introduced into mRNA, termination of the translationposttranslational modification reaction can be per-
formed using hydrazine-tagged molecules [20]. The effi- reaction occurs after the 4-base codon because it re-
mains in the “zero reading frame” and encounters a stopciency of Flexiresin-catalyzing tRNA aminoacylation
with p-aceto-Phe (AcPhe) was 45.0%  1.2% deter- codon therein (see Figure 3B). By reading through the
4-base codon with the frame-shift suppressor tRNAmined by streptavidin-dependent gel-shift assay, and
this nonnatural amino acid was incorporated into the bearing the corresponding 4-base anticodon, transla-
tion can continue in the “1” frame and hence the full-position 151 with 28.9%  0.9% suppression efficiency
(data not shown). This mutant protein was then treated length protein is produced. It has been shown that
4-base codons can be designed based on less abundantwith biotin-hydrazide and the 151 keto residue was se-
lectively tagged with the biotin molecule. As expected, codons in E. coli, such as Arg CGG, Arg AGG, or Gly
GGG; hence, the 4-base codon consists of CGGN,the gel mobility of the biotin-modified protein was re-
tarded in the presence of streptavidin (Figure 5A) and AGGN, or GGGN [22, 23]. We prepared pairs of 4-base
codons and the corresponding frame-shift suppressorpulled down by streptavidin-agarose (Figure 5B),
whereas the wild-type was not. Thus, site-specific post- tRNA mutants and screened appropriate combinations
for RTS activity using Bzo as the nonnatural amino acid.translational modification can be performed with a vari-
ety of hydrazide molecules. We found that an orthogonal E. coli tRNAAsnACCC sup-
A Ribozyme Aminoacylation System for Translation
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Figure 5. Posttranslation Modification of AcPhe at Position 151
(A) Streptavidin-dependent gel-shift assay for the wild-type and biotinylated 151AcPhe mutant GFPs. Approximately 80% of the mutant GFP
band was retarded by the addition of streptavidin, whereas no shift was observed for wild-type. Abbreviations: SAv, streptavidin; wt, wild-
type.
(B) Streptavidin-agarose capture of the mutant GFP. Streptavidin-agarose was successfully used to capture the biotinylated mutant GFP and
concentrated on the resin, whereas no capture was observed for wild-type. Abbreviation: SAv-aga, streptavidin-agarose.
presses the corresponding frame-shift mutation (GGGU)
most efficiently in RTS (H.M. and H.S., unpublished
data).
By combining the amber and the programmed frame-
shift codons [24], we attempted to incorporate two Phe
analogs (Iod and Bip, see Figure 2A) into GFP at two
specific sites (Figure 3B). We chose positions 151 and
178 to have the UAG and GGGU mutations, respectively.
Two corresponding suppressor tRNAs, tRNAAsnCUA and
tRNAAsnACCC, were charged with Bip and Iod via Flexiresin
(Figure 2C, lanes 5 and 9, respectively) and used to
suppress these mutations. As expected, the full-length
GFP could be translated only in the presence of both
suppressor tRNAs (Figures 6A–6C, lane 6), whereas the
expected truncated proteins were observed in the pres-
ence of either of the charged tRNAs, as expected (lanes
2–5). These results support the incorporation of two
nonnatural amino acids into the designated positions of
the mutant GFP.
Conclusion and Outlook
We have demonstrated that the combination of a resin-
immobilized form of an ARS ribozyme, called Flexiresin,
and a high-performance cell-free translation system fa-
cilitates the mutagenesis of proteins with nonnatural
amino acids. Owing to the flexible feature of Flexiresin
toward different aromatic amino acid and tRNA sub-
strates, this single catalytic system can be applied to a
variety of user-specified combinations. The method is
simple and practical in terms of the preparation of the
Flexiresin as well as the procedures for the synthesis
and isolation of aminoacyl-tRNAs. Moreover, the dura-
bility and recyclability of Flexiresin make this technology
Figure 6. Nonnatural Amino Acid Mutagenesis of GFP at 151/178
economical. Most importantly, the methods used through-
(A) SDS-PAGE analysis of the translation reaction. Abbreviations:out these studies, including the cell-free translation, are
x, no tRNA;, no aa-tRNA;, aa-tRNA; wt, wild-type; (a), full-length
not specialized, and therefore, nonnatural amino acid protein; (b), truncated peptide at position 180 (failed frame shift);
mutagenesis becomes a user-accessible technology. (c), truncated peptide at position 151 (amber stop codon).
(B) Fluorescent activity of each sample in (A), analyzed by MolecularThe flexibility of Flexiresin is perhaps even more signif-
Imager FX.icant when other applications are considered. For in-
(C) Suppression efficiency. The suppression efficiency was calcu-stance, the combinations of amber and 4-base codons
lated based the radioisotope of the bands of (a), (b), and (c), fittedwill allow us to readily reprogram the genetic code with
to (a)/[(a)(b)x5/3(c)x5/3]. The middle of the error bar represents
more than two nonnatural amino acids [24–26]. Site- the mean score from three different trials. The error bar represents
specific multiple mutations with unique nonnatural amino a standard deviation of all trials.
acids, such as fluorophores or spin labels, provide a new
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AGTCCGC CGTTCTACCG ACTGAACTAC AGAGGC-3, XXX  TAGtool for studying protein dynamics [24, 27–29]. Flexiresin
or GGGT), P5-3 (5-ACGCATATGT AATACGACTC ACTATAGCCTcan be used for the synthesis of nonnatural aminoacyl-
CTGTAGTTCAG TCGGT-3), and P3-3 (5-TGGTGCCTCT GACTGtRNAs that are orthogonal in other translation systems,
GACTC-3).
e.g., rabbit reticulocyte lysate and wheat germ extract The corresponding 5- and 3-primers (P5-1 and P3-1) were used
[30], both of which are suitable for translating mRNAs to amplify the template DNA (Fx) coding the Flexizyme sequence,
and the resulting dsDNA was further amplified using the shorteror cDNAs derived from eukaryotic cells. For example,
primers (P5-2 and P3-2). The corresponding 5- and 3-primers (P5-3an amber suppressor tRNA derived from E. coli tRNATyr
and P3-3) were used to amplify the template DNA (tR) coding theis known to be orthogonal in wheat germ translation
engineered tRNAAsn, and the resulting dsDNA was further amplifiedsystem [13], and hence, the Flexiresin method can be
using the shorter primers (P5-2 and P3-3). The Fx dsDNA or tR
readily applied to the preparation of the corresponding dsDNA was in vitro transcribed in the presence of 7.5 mM GMP,
aminoacyl-tRNAs. Similarly, Flexiresin allows users to 3.75 mM each NTPs, and the RNA transcript was purified by 6%
denaturing PAGE. For the aminoacylation assay, body-radiolabeledsynthesize suitable aminoacyl-tRNAs that can be im-
tRNA was synthesized using the same protocol except for the pres-ported into COS1 cells [31] or Xenopus oocyte [32], thus
ence of [-32P]GTP in the transcription reaction.expressing proteins containing nonnatural amino acids
in vivo. Thus, this new enabling technology based on
Preparation of Resin-Immobilized Flexizyme
Flexiresin allows for nonnatural amino acid mutagenesis Freshly prepared 0.1 M NaIO4 (400 L) was added to 28.1 M Flexi-
to become more accessible for many researchers. zyme (1 mL), and the mixture was incubated at 0C for 20 min.
Yet we still need more investigations in order to adapt The 3-dialdehyde RNA was precipitated with 14 ml of 2% lithium
perchlorate in acetone followed by a 1 ml wash with acetone. Thethis technology to a variety of applications. Flexiresin
pellet was dissolved in 1.4 ml of 0.1 M sodium acetate (pH 5.) andis able to charge a fairly wide range of aromatic amino
then mixed with 0.7 ml adipic acid dihydrazide-agarose that wasacids, including those not shown in this study, such as
prewashed with DEPC-treated water. The reaction solution was
N-alkyl-Phe and tryptophan analogs onto tRNAs (D.K., mixed at room temperature for 3 hr. The resulting imine moiety of
H.M., and H.S., unpublished data), but the full scope of the RNA-resin was reduced by adding 1 M sodium cyanoborohy-
Phe analogs has not been fully investigated. On the dride (300 L) and then was incubated at room temperature for 30
min. The agarose was washed with 1.4 ml of W1 (consisting of 0.1other hand, it is clear that Flexiresin is unable to charge
M sodium acetate buffer [pH 5.0] containing 300 mM NaCl, 7.5 Mnonnatural amino acids possessing aliphatic side chains
urea, and 0.1% sodium dodecyl sulfate) and then suspended in 2.1[14, 33]. Although our previous studies on Flexizyme
ml of W1. The immobilization efficiency was estimated by the
and its parental ribozyme have revealed the potential amount of the recovered ribozyme in the flow through based on
bases involved in Phe binding [33], the exact mode of absorbance at UV260. The Flexizyme-resin (Flexiresin) can then be
the substrate recognition is unknown. Perhaps further stored in 4C. Before the aminoacylation reaction, Flexiresin is
washed with 4 volumes of DEPC-treated water three times and thenstructural characterizations of the ribozyme, e.g., by
suspended in three-resin volumes of DEPC-treated water.means of X-ray crystallography, would help in under-
standing such details. However, even without a high-
Preparation of Amino Acid Substratesresolution structure, our accumulated knowledge of the
The same procedure as previously described [14] was used to syn-
critical residues in Flexizyme [15, 33–35] would facilitate thesize cyanomethyl ester of Phe (phenylalanine), Bzo (p-benzoyl-
the design of doped RNA pools such that rapid in vitro phenylalanine), and Azo (p-phenylazophenylalanine), Iod (p-iodo-
evolution could be carried out. These studies are cur- phenylalanine), Bip (p-biphenylalanine), Azi (p-azidophenylalanine),
and AcPhe (p-acetylphenylalanine) from the corresponding N-Bocrently underway in our laboratory.
amino acids. Bio (p-biotinyl-aminophenylalanine) was synthesized
from N-Boc-p-aminophenylalanine and biotin-NHS, followed by the
Significance same procedure as above.
Aminoacylation of tRNA on FlexiresinThe resin-immobilized ribozyme, called Flexiresin, is
The following conditions were generally used for analytical pur-able to charge a wide range of Phe analogs onto engi-
poses: 5 l Flexiresin suspended in DEPC-treated water (the resinneered amber and frame-shift suppressor tRNAs.
volume is 1.2 l corresponding to 7.5–10 M ribozyme concentra-Flexiresin can be readily prepared and stored at 4C,
tion) was taken to a microtube, and the supernatant was removed
and most importantly, it is recyclable. This technology to leave the resin. Folded tRNA (2.25 l of 12 M) in EKM buffer
was coupled with a high-performance cell-free trans- [pH 7.0, 50 mM N-(2-hydroxyethyl)piperazine-N-(3-propanesulfonic
acid) (EPPS), 12.5 mM KCl, 1.2 M MgCl2] was added to the resin onlation system, and Phe analogs were incorporated into
ice, and then added to this mixture was 0.25 l of 50 or 100 mMa model protein at one or two specific sites. Thus, the
amino acid substrate followed by 0.1 l of 0.25 M KOH (to adjustsolid phase ribozyme aminoacylation system would
pH to 7.0–7.2). After 2 hr incubation on ice, the supernatant wasenable many researchers to perform protein mutagen-
removed, and the resin was washed with 5 l of EK buffer (pH 7.5)
esis using nonnatural amino acids with greater ease. containing 10 mM EDTA at room temperature three times to elute
the aminoacyl-tRNA product. After addition of 0.75l of 3.0 M potas-
sium acetate (approximately 0.15 M final concentration), the amino-Experimental Procedures
acyl-tRNA was precipitated by the addition of 30 l of ice-cold
ethanol. After 5 min on dry ice, the tube was centrifuged, the pelletPreparation of Ribozymes and tRNAs
The following nucleotides were chemically synthesized and purified was washed with 70% ethanol, and dried under vacuum.
For analysis of aminoacylation efficiency, selective biotinylationby 6% denaturing polyacrylamide gel electrophoresis (PAGE): Fx
(5-ACCTAACGCC AATACCCTTT CGGGCCTGCG GAAATCTTTC of the -amino group of aminoacyl-tRNA was carried out as follows
[14, 36]. The pellet was dissolved in 2.5 l of EPPS (0.1 M; pH 5.9)GATCC-3), P5-1 (5-ACGCATATGT AATACGACTC ACTATAGGAT
CGAAAGATTT CCGC-3; T7 promoter sequence is italicized), P5-2 containing 20 mM biotin-3-sulfo-N-hydroxylsuccinimide ester, and
after cooling on ice, the reaction was initiated by the addition of(5-GGTAACACGC ATATGTAATA CGACTC-3), P3-1 (5-T20ACC
TAACGCC AATACCCTTT-3), P3-2 (5-T20 ACCTAACGCC-3), tR (5- 0.86 l of EPPS-KOH (0.3 M; pH 9.1, which brought the pH to 8.0).
After 1 hr, the reaction was terminated by ethanol precipitation, andTGGTGCCTCT GACTGGACTC GAACCAGTGA CATACGGATT XXX
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the pellet was washed with 70% ethanol and dissolved into 10 l bation, 0.75 l of 1 M NaCNBH3 was added and the reaction mixture
was incubated for another 24 hr to reduce the imine bond. To removeof water. A 1 l portion of the RNA solution was mixed with 4 l of
the loading buffer (0.62 mg/mL streptavidin, 50 mM EDTA, 33 mM the excess amount of biotin-LC-hydrazide, the solution was first
diluted with 200 l of 10 mM Tris-HCl (pH 8.8) and centrifuged topiperazine-NN-bis-[2-ethanesulfonic acid] [pH 6.1], 6 M urea),
heated for 30 s at 95C, and then cooled to 25C. This sample was remove any insoluble reagents. The solution was then applied to
BSA-precoated Microcon YM-10 (Millipore) and spun to remove anyanalyzed by 8% denaturing PAGE, performed in a cold room in order
to keep the gel temperature below 20C. Under these conditions, unreacted biotin. The solution that did not pass through the filter
was diluted with 500 l of 10 mM Tris-HCl (pH 8.8). After six morethe streptavidin-biotin complex is stable to retard the aminoacyl-
tRNA band, but the RNA structure is mostly denatured. The radioiso- dilutions and subsequent spinning, the solution was collected. The
collected proteins were analyzed by streptavidin gel-shift assaytope of each band was quantified using the Quantity One program
equipped with Molecular Imager FX (Bio-Rad). using 10% native PAGE. For the streptavidin-agarose capturing ex-
periment, 5 l of streptavidin-agarose (Pierce) was added to theFor a semipreparative scale, the reaction volume described above
was scaled up 20 or 200 times depending upon the needs. For protein and incubated for 10 min. The resulting mixture was then
diluted with 200 l of 0.1 M Tris-HCl (pH 8.8), and the fluorescenceexample, a total of 450 l tRNA aminoacylation reaction volume
(approximately 150 l resin was involved) was generally needed for of the protein was analyzed using Molecular Imager FX (Bio-Rad).
100 l of translation. A disposable spin column (Bio-Rad) was used
for this scale instead of the conventional microtube. After the amino- Acknowledgments
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